WallStreetZenWallStreetZen

NASDAQ: NEPH
Nephros Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NEPH stock forecasts and price targets.

Forecast return on equity

Is NEPH forecast to generate an efficient return?

Company
29.62%
Industry
20.2%
Market
148.77%
NEPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NEPH forecast to generate an efficient return on assets?

Company
22.48%
Industry
14.49%
NEPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NEPH earnings per share forecast

What is NEPH's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.16+6.53%
Avg 2 year Forecast
$0.27+76.8%
Avg 3 year Forecast
$0.33+117.6%
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NEPH revenue forecast

What is NEPH's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$22.6M+8.91%
Avg 2 year Forecast
$26.2M+26.29%
Avg 3 year Forecast
$29.7M+43.18%
NEPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NEPH earnings growth forecast

How is NEPH forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
29.3%
Industry
43.19%
Market
62.71%
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NEPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NEPH revenue growth forecast

How is NEPH forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
12.31%
Industry
7.73%
Market
14.95%
NEPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NEPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NEPH vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
NEPH$4.55N/AN/A
POCI$4.40N/AN/A
MLSS$0.50N/AN/A
HBIO$7.93$7.50-5.42%Buy
ZTEK$0.54N/AN/A
View Top Medical Stocks

Nephros Stock Forecast FAQ

What is NEPH's earnings growth forecast for 2026-2028?

(NASDAQ: NEPH) Nephros's forecast annual earnings growth rate of 29.3% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 43.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 62.71%.

Nephros's earnings in 2026 is $1,736,000.On average, 5 Wall Street analysts forecast NEPH's earnings for 2026 to be $1,735,447, with the lowest NEPH earnings forecast at $1,596,438, and the highest NEPH earnings forecast at $1,938,531. On average, 4 Wall Street analysts forecast NEPH's earnings for 2027 to be $2,880,104, with the lowest NEPH earnings forecast at $2,235,013, and the highest NEPH earnings forecast at $3,534,969.

In 2028, NEPH is forecast to generate $3,544,743 in earnings, with the lowest earnings forecast at $3,405,734 and the highest earnings forecast at $3,649,000.

If you're new to stock investing, here's how to buy Nephros stock.

What is NEPH's revenue growth forecast for 2026-2028?

(NASDAQ: NEPH) Nephros's forecast annual revenue growth rate of 12.31% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.95%.

Nephros's revenue in 2026 is $20,722,000.On average, 5 Wall Street analysts forecast NEPH's revenue for 2026 to be $245,091,188, with the lowest NEPH revenue forecast at $231,266,255, and the highest NEPH revenue forecast at $254,821,856. On average, 4 Wall Street analysts forecast NEPH's revenue for 2027 to be $284,198,480, with the lowest NEPH revenue forecast at $271,622,461, and the highest NEPH revenue forecast at $294,092,050.

In 2028, NEPH is forecast to generate $322,219,760 in revenue, with the lowest revenue forecast at $309,578,581 and the highest revenue forecast at $331,689,785.

What is NEPH's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: NEPH) forecast ROA is 22.48%, which is higher than the forecast US Medical Instruments & Supplies industry average of 14.49%.

What is NEPH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NEPH) Nephros's current Earnings Per Share (EPS) is $0.15. On average, analysts forecast that NEPH's EPS will be $0.16 for 2026, with the lowest EPS forecast at $0.15, and the highest EPS forecast at $0.18. On average, analysts forecast that NEPH's EPS will be $0.27 for 2027, with the lowest EPS forecast at $0.21, and the highest EPS forecast at $0.33. In 2028, NEPH's EPS is forecast to hit $0.33 (min: $0.31, max: $0.34).

What is NEPH's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: NEPH) forecast ROE is 29.62%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.